Literature DB >> 1909196

Ig VH gene expression among human follicular lymphomas.

D W Bahler1, M J Campbell, S Hart, R A Miller, S Levy, R Levy.   

Abstract

Thirty-six randomly selected cases of low grade follicular lymphoma (FL) were analyzed for Ig heavy chain variable region (VH) gene expression. Assignment to one of the six human VH gene families (VH1 to VH6) was made with a polymerase chain reaction-based technique using family-specific leader primers. The frequency of VH family use in FL was found to be similar to that reported for normal peripheral blood lymphocytes and is therefore also roughly proportional to VH family size. To evaluate expression within an individual family, all of the lymphoma VH genes from the middle size VH4 family were sequenced and compared with previously published sequences. Of these eight lymphoma VH sequences, six were most closely related to just two of the 10 known functional VH4 germline genes. Nonrandom usage by FL of the JH3, JH4, and JH5 joining segments was also observed. Nucleotide sequences were also determined for 10 randomly selected lymphoma VH genes from the large VH3 family. With one possible exception, none of these lymphoma VH sequences appear to represent any of the VH3 genes that may be preferentially used in the fetal repertoire.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909196

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Assessment of IgH PCR strategies in multiple myeloma.

Authors:  R G Owen; R J Johnson; A C Rawstron; P A Evans; A Jack; G M Smith; J A Child; G J Morgan
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

2.  Major histocompatibility complex-restricted recognition of autologous chronic lymphocytic leukemia by tumor-specific T cells.

Authors:  W Sherman; Z Liu; G Inghirami; E F Reed; P E Harris; N M Suciu-Foca
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

3.  Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas.

Authors:  I S Lossos; A A Alizadeh; M B Eisen; W C Chan; P O Brown; D Botstein; L M Staudt; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 4.  Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis.

Authors:  Sarah H Walsh; Richard Rosenquist
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

5.  Increased sensitivity of B-cell clonality analysis in formalin-fixed and paraffin-embedded B-cell lymphoma samples using an enzyme blend with both 5'-->3' DNA polymerase and 3'-->5' exonuclease activity.

Authors:  Timea P Gurbity; Eniko Bagdi; Nicole A Groen; Leo M Budel; Mustaffa Abbou; Laszlo Krenacs; Winand N M Dinjens
Journal:  Virchows Arch       Date:  2003-08-21       Impact factor: 4.064

6.  Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa.

Authors:  David W Bahler; Philippe Szankasi; Sucheta Kulkarni; Raymond R Tubbs; James R Cook; Steven H Swerdlow
Journal:  Mod Pathol       Date:  2009-06       Impact factor: 7.842

7.  Clonal evolution of a follicular lymphoma: evidence for antigen selection.

Authors:  D W Bahler; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 8.  Chlamydial infection: the link with ocular adnexal lymphomas.

Authors:  Andrés J M Ferreri; Riccardo Dolcetti; Simone Magnino; Claudio Doglioni; Maurilio Ponzoni
Journal:  Nat Rev Clin Oncol       Date:  2009-10-06       Impact factor: 66.675

9.  Chronic lymphocytic leukemia with t(14;18)(q32;q21).

Authors:  Guilin Tang; Haley E Banks; Rachel L Sargent; L Jeffrey Medeiros; Lynne V Abruzzo
Journal:  Hum Pathol       Date:  2012-10-16       Impact factor: 3.466

10.  A molecular analysis of biclonal follicular lymphoma: further evidence for bone marrow origin and clonal selection.

Authors:  Yuichi Nakamura; Yasutaka Sato; Katsuhiko Yoshida; Emi Kakegawa; Yoshihiro Ito; Atsushi Seyama; Hidekazu Kayano; Masami Bessho
Journal:  Eur J Haematol       Date:  2009-02-05       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.